Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model
Juwon Park(Seoul National University), Sung‐Soo Yoon(Seoul National University Hospital), Kyung Im Kim(Korea University), Youngil Koh(Seoul National University), Dong Soon Lee(Seoul National University Hospital), Kwang‐Sung Ahn(Seoul National University Hospital), Nam-Hee Won(Korea University), Byoung Kook Kim(Seoul National University), Jung Mi Oh(Seoul National University)
Cited by 3
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Patterns of somatic structural variation in human cancer genomes
|Nature|2020|999
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
|The Lancet|2023|194